Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them.

Weight-loss drug Wegovy produces 'largest benefit ever seen' for patients with most common form of heart failure, trial finds

Wegovy cuts heart risks by 20% in large trial

Wegovy cuts risk of cardiovascular events by 20%, study finds

Wegovy cuts risk of serious heart problems by 20%, study finds

Weight-loss drug Wegovy may benefit patients with heart failure

Obesity drug Wegovy reduces serious heart disease risk by 20%: Study

MUSC involved in study that found weight loss drug reduced risk of heart problems, MUSC

Scientists hope weight-loss drugs could treat addiction and dementia, Dementia

Watch CBS Evening News: Wegovy may cut cardiovascular risk - Full show on CBS

Obesity drug wegovy cut risk of serious heart problems by 20%, study finds : r/WegovyWeightLoss

Novo Nordisk's Wegovy Posts Trial Data Supporting the Drug as Way to Lower Heart Risks - MedCity News

Wegovy Prevents Heart Risks by 20%